10 results
Equianalgesic Opioid Dosing 

#Pharmacology #Pain #Opioid #Opiate #Conversion #Equianalgesic #Table
Equianalgesic Opioid Dosing ... #Pharmacology ... #Pain #Opioid # ... Opiate #Conversion ... Equianalgesic #Table
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Pain Assessment ... #Management #Pain ... #Pharmacology # ... Opioid #Opiate # ... #Table #PAMI
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Adjusted Pain Medication ... Dosing based on ... #Pain #Pharmacology ... #Opiates #CKD # ... Gabapentin #Table
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
are subcutaneous injections ... GI tract) and injection ... site pain. --- ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... Table A 3. ... Then using Table ... #Pharmacology #Pain ... #Opiate #Opioid
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Ozempic), or daily tablet ... Receptor #Agonists #Pharmacology ... DM2 #diabetes #endocrinology
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... anti-infectives ... IV to PO anti-infectives ... #pharmacology #antibiotics ... #medications #table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... normally inactivates GLP ... combination therapy with GLP-I ... Toxicities: • Joint pains ... DM2 #diabetes #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... oral route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Orthopedic Dressing Materials
1. Opsite - semi-permeable-thin, adhesive transparent polyurethrane film 
 • Indications: Superficial wounds as
Opsite - semi-permeable-thin ... antiseptics or antibiotics ... recommended in anearobic infections ... Contraindications: Dry wound, infection ... wound #comparison #table